Neuronal nicotinic acetylcholine receptor agonists

By Toma Lucio   Barlocco Daniela   Gelain Arianna  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1029-1040

Informa Healthcare

Access to resources Recommend Favorite

CI-1017, a functionally M 1 -selective muscarinic agonist: design, synthesis, and preclinical pharmacology

By Tecle H.   Schwarz R.D.   Barrett S.D.   Callahan M.J.   Caprathe B.W.   Davis R.E.   Doyle P.   Emmerling M.   Lauffer D.J.   Mirzadegan T.   Moreland D.W.   Lipiniski W.   Nelson C.   Raby C.   Spencer C.   Spiegel K.   Thomas A.J.   Jaen J.C.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 141-148

Elsevier

Access to resources Recommend Favorite

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice

By Rabenstein R.   Caldarone B.   Picciotto M.  

Psychopharmacology, Vol. 189, Iss. 3, 2006-12 ,pp. : 395-401

Springer Publishing Company

Access to resources Recommend Favorite

5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor

By Blanton M.P.   McCardy E.A.   Fryer J.D.   Liu M.   Lukas R.J.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite

A new look at the neuronal nicotinic acetylcholine receptor pharmacophore

By Sarkar A.   Ramesh R.   Somayajulu B.L.K.   Agnihotri R.   Jull A.J.T.   Burr G.S.   Curtis L.   Chiodini F.   Spang J.E.   Bertrand S.   Patt J.T.   Westera G.   Bertrand D.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite